Open AccessSerum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
Author(s) -
Katia Farias E Silva,
Hayandra F. Nanini,
Cynthia Machado Cascabulho,
Siane Lopes Bittencourt Rosas,
Patrícia Teixeira Santana,
Antonio José V. Carneiro,
Elias Anaissie,
Márcio Nucci,
Heitor Siffert Pereira de Souza
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i9.866
Subject(s) - inflammatory bowel disease , medicine , inflammatory bowel diseases , gastroenterology , disease , beta glucan , pathology , ulcerative colitis , inflammation , immunology , glucan , chemistry , biochemistry
1,3-beta-D-glucan (BG) is a ubiquitous cell wall component of gut micro-organisms. We hypothesized that the serum levels of BG could reflect active intestinal inflammation in patients with inflammatory bowel disease.